ReviewBiomolecules2020

Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs.

Thomas Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.